logo

BCRX’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience

HCCC Stock

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 21.37%.However, over the last six months, we can see a weaker performance of 19.38%. Over the last 30 days, the price of BCRX has fallen by 17.83%. And in the last five days, it has surged by 12.02%.

Biocryst Pharmaceuticals Inc.’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $7.95 on 07/27/23, with the lowest value being $4.03 on 04/25/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

52-week price history of BCRX Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Biocryst Pharmaceuticals Inc.’s current trading price is -8.55% away from its 52-week high, while its distance from the 52-week low is 80.40%. The stock’s price range over this timeframe has been between $4.03 and $7.95. The shares of the Healthcare sector company recorded a trading volume of approximately 3.7 million for the day, which was comparatively higher than the average daily volume of 3.69 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Biocryst Pharmaceuticals Inc. (BCRX) has experienced a quarterly rise of 57.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.50B and boasts a workforce of 536 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.63, with a change in price of +1.45. Similarly, Biocryst Pharmaceuticals Inc. recorded 3,540,904 in trading volume during the last 100 days, posting a change of +24.91%.

BCRX Stock Stochastic Average

The raw stochastic average for Biocryst Pharmaceuticals Inc. over the last 50 days is presently at 86.75%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 77.81%. Further, the company’s Stochastic %K and %D values for the last 20 days were 86.71% and 89.27%, respectively.

Most Popular